Form D — Acurx Pharmaceuticals, Inc.
0001736243-25-000001 · filed 2025-01-17
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $2,404,259
- Total sold
- $2,404,259
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Acurx Pharmaceuticals, Inc.
- CIK
- 1736243
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 259 LIBERTY AVENUE
STATEN ISLAND, NY 10305 - Phone
- 917-533-1469
Related persons
-
David P. Luci · Executive OfficerStaten Island, NY
-
Robert J. DeLuccia · Executive OfficerStaten Island, NY
-
Robert G. Shawah · Executive OfficerStaten Island, NY
-
Jack H. Dean · DirectorStaten Island, NY
-
James Donohue · DirectorStaten Island, NY
-
Thomas Harrison · DirectorStaten Island, NY
-
Carl Sailer · DirectorStaten Island, NY
-
Joseph Scodari · DirectorStaten Island, NY
View original on SEC EDGAR.